Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf-β1 under the control of dietary xylan

Zaed Z.R. Hamady, Nigel Scott, Mark D. Farrar, Meenu Wadhwa, Paula Dilger, Terence R. Whitehead, Robin Thorpe, Keith T. Holland, Peter J.A. Lodge, Simon R. Carding
  • Inflammatory Bowel Diseases, September 2011, Wolters Kluwer Health
  • DOI: 10.1002/ibd.21565

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Terence R Whitehead and Dr Mark D Farrar